Veterinary Healthcare Market

Veterinary healthcare focuses on effective animal health management by diagnosing and treating diseases. It is a medical specialty concerned with the prevention, diagnosis, control, and treatment of diseases affecting the health of domestic and wild animals, as well as to prevent transmission of veterinary diseases (zoonotic and chronic) worldwide. Early detection is key when it comes to treating health problems in animals.

Market Dynamics:

Increase in incidence/prevalence of zoonosis diseases, increase in focus on veterinary healthcare, favorable initiatives by governments and animal welfare associations, increase in awareness about veterinary healthcare, rise in adoption of pets, and introduction of novel products are major factors expected to drive growth of the global veterinary healthcare market.

For instance, in September 2019, Abu Dhabi Agriculture and Food Safety Authority (ADAFSA) launched the 11th annual vaccination campaign for 2019-2020 against diseases affecting animals in the Emirate of Abu Dhabi. The campaign comes as part of ADAFSA's great support for livestock breeders in the emirate, to promote the best practices related to animal farming.

Moreover, in May 2020, Felix Pharmaceuticals Pvt. Ltd. announced that the U.S. Food and Drug Administration (FDA) approved its ‘Enrofloxacin Flavored Tablets’, for the treatment of diseases associated with bacteria.

Key features of the study:

• This report provides in-depth analysis of the global veterinary healthcare market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global veterinary healthcare market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Zoetis Inc., Virbac SA, Vetoquinol SA, Phibro Animal Health, Merck & Co. Inc., IDEXX Laboratories, Ceva SantE Animale, BioMérieux SA, Elanco Animal Health Incorporated, and Boehringer Ingelheim International GmbH, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global veterinary healthcare market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary healthcare market.

Detailed Segmentation:

• Global Veterinary Healthcare Market, By Product:
  • Therapeutics
  • Diagnostics
• Global Veterinary Healthcare Market, By Animal Type:
  • Dogs and Cats
  • Horses
  • Ruminants
  • Swine
  • Poultry
  • Other Animals
• Global Veterinary Healthcare Market, By Geography:
  • North America
  • Europe
  • Asia-Pacific
  • Middle East and Africa
  • South America
• Company Profiles:
  • Zoetis Inc.
  • Virbac SA
  • Vetoquinol SA
  • Phibro Animal Health
  • Merck & Co. Inc.
  • IDEXX Laboratories
  • Ceva SantE Animale
  • BioMérieux SA
  • Elanco Animal Health Incorporated
  • Boehringer Ingelheim International GmbH